{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:17:17Z","timestamp":1785104237664,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002403","name":"Taibah University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021672","name":"NIHR Leicester Clinical Research Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jaip.2021.05.041","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:50:52Z","timestamp":1623988252000},"page":"4279-4287.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma"],"prefix":"10.1016","volume":"9","author":[{"given":"Fahad H.","family":"Alahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Keevil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Elsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Niven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.05.041_bib2","first-page":"329","article-title":"Nonadherence in difficult asthma\u2013facts, myths, and a time to act","volume":"7","author":"Lindsay","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaip.2021.05.041_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)63001-3","article-title":"Nonadherence in asthmatic patients: is there a solution to the problem?","volume":"79","author":"Bender","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.041_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.rmed.2015.07.016","article-title":"Long-term adherence to inhaled corticosteroids in children with asthma: observational study","volume":"109","author":"Klok","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.05.041_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1440-1843.2008.01292.x","article-title":"Assessing adherence and factors associated with adherence in young children with asthma","volume":"13","author":"Burgess","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2021.05.041_bib6","series-title":"Global Strategy for Asthma Management and Prevention","year":"2019"},{"key":"10.1016\/j.jaip.2021.05.041_bib7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1097\/HJH.0000000000000346","article-title":"Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension","volume":"32","author":"Chung","year":"2014","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jaip.2021.05.041_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1081-1206(10)62557-4","article-title":"Measurement of children\u2019s asthma medication adherence by self report, mother report, canister weight, and Doser CT","volume":"85","author":"Bender","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.041_bib9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2021.05.041_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201204-0587OC","article-title":"The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma","volume":"186","author":"McNicholl","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.05.041_bib11","first-page":"995","article-title":"Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil","volume":"34","author":"Santos","year":"2008","journal-title":"J\u00a0Brasil Pneumol"},{"key":"10.1016\/j.jaip.2021.05.041_bib12","doi-asserted-by":"crossref","first-page":"1700910","DOI":"10.1183\/13993003.00910-2017","article-title":"Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children","volume":"50","author":"Jochmann","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.05.041_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/thoraxjnl-2015-208171","article-title":"STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma","volume":"72","author":"Morton","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2021.05.041_bib14","first-page":"1","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaip.2021.05.041_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jsbmb.2009.12.007","article-title":"Steroid measurement with LC\u2013MS\/MS. Application examples in pediatrics","volume":"121","author":"Rauh","year":"2010","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jaip.2021.05.041_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2500\/aap.2012.33.3568","article-title":"Urinary fluticasone propionate-17beta-carboxylic acid to assess asthma therapy adherence","volume":"33","author":"Hagan","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2021.05.041_bib17","first-page":"A96","article-title":"P15 Detection of inhaled corticosteroids in the serum\u2013relationship to adherence and markers of asthma severity","volume":"74","author":"Alahmadi","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2021.05.041_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaci.2016.08.037","article-title":"A\u00a0pilot study to investigate the use of serum inhaled corticosteroid concentration as a potential marker of treatment adherence in severe asthma","volume":"139","author":"George","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.041_bib20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/1744666X.2018.1532290","article-title":"Adherence to medication in children and adolescents with asthma: methods for monitoring and intervention","volume":"14","author":"Pearce","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.041_bib21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1164\/rccm.201604-0733OC","article-title":"Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease","volume":"195","author":"Sulaiman","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.05.041_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.rmed.2012.12.007","article-title":"Inhaler devices\u2013from theory to practice","volume":"107","author":"Sanchis","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.05.041_bib23","doi-asserted-by":"crossref","first-page":"e0187835","DOI":"10.1371\/journal.pone.0187835","article-title":"Criterion validity of 8-item Morisky Medication Adherence Scale in patients with asthma","volume":"12","author":"Jane\u017ei\u010d","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2021.05.041_bib24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/02770903.2016.1180699","article-title":"Is the MARS questionnaire a reliable measure of medication adherence in childhood asthma?","volume":"53","author":"Garcia-Marcos","year":"2016","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2021.05.041_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaip.2013.03.001","article-title":"Development and preliminary validation of the Adult Asthma Adherence Questionnaire\u2122","volume":"1","author":"Schatz","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.041_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaci.2011.10.030","article-title":"Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial","volume":"129","author":"Krishnan","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.041_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2125.2007.02856.x","article-title":"Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction","volume":"64","author":"Mortimer","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.05.041_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2125.2006.02712.x","article-title":"Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma","volume":"62","author":"Mortimer","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.05.041_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/thorax.58.3.258","article-title":"Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects","volume":"58","author":"Harrison","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2021.05.041_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(00)02581-2","article-title":"Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study","volume":"356","author":"Brutsche","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.05.041_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00074905","article-title":"Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma","volume":"28","author":"Derendorf","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.05.041_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bcp.12637","article-title":"Inhaled corticosteroids: potency, dose equivalence and therapeutic index","volume":"80","author":"Daley-Yates","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.05.041_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0091270003260334","article-title":"Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic\/pharmacodynamic perspective","volume":"44","author":"Rohatagi","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.05.041_bib34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/rccm.200902-0166OC","article-title":"The prevalence of nonadherence in difficult asthma","volume":"180","author":"Gamble","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.05.041_bib35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/thx.53.12.1030","article-title":"Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids","volume":"53","author":"Stirling","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2021.05.041_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.105.085217","article-title":"Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma","volume":"314","author":"Belvisi","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jaip.2021.05.041_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000062132","article-title":"Ciclesonide: an on-site-activated steroid","volume":"31","author":"Dietzel","year":"2001","journal-title":"Prog Respir Res"},{"key":"10.1016\/j.jaip.2021.05.041_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMPed.S4311","article-title":"Similar results in children with asthma for steady state pharmacokinetic parameters of ciclesonide inhaled with or without spacer","volume":"4","author":"Boss","year":"2010","journal-title":"Clin Med Insights Pediatr"},{"key":"10.1016\/j.jaip.2021.05.041_bibE1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.05.041_bibE2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201204-0587OC","article-title":"The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma","volume":"186","author":"McNicholl","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.05.041_bibE3","first-page":"995","article-title":"Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil","volume":"34","author":"Santos","year":"2008","journal-title":"J\u00a0Bras Pneumol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821006693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821006693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:29:46Z","timestamp":1761974986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821006693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2213219821006693"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.05.041","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}